US Broker Ratings

Centene Corporation (CNC) Stock Analysis: Exploring a 37.50% Potential Upside in the Healthcare Sector

Centene Corporation (NYSE: CNC) stands as a formidable player in the U.S. healthcare sector, specializing in healthcare plans and services that cater to under-insured and uninsured..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a 26% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents a compelling narrative. With a market capitalization of $31.89 billion, this..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a 4.54% Growth Potential in the Healthcare Giant

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture the interest of investors with its robust market presence and potential for..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a 10.27% Upside Potential and Robust Growth Metrics

As one of the leading entities in the U.S. medical care facilities industry, HCA Healthcare, Inc. (NYSE: HCA) presents a compelling investment opportunity. With a market..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating Growth Potential with a 9.17% Upside

AbbVie Inc. (NYSE: ABBV), a powerhouse in the healthcare sector, continues to capture investor attention with its robust pipeline of biopharmaceutical innovations. With a commanding market..

Becton, Dickinson (BDX) Stock Analysis: A Compelling 18% Upside Potential for Healthcare Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, stands out with a market capitalization of $50.55 billion. As a leader in medical..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: A 19.39% Potential Upside Despite Revenue Challenges

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, may catch the discerning eye of investors searching for value in the pharmaceutical..

GSK plc (GSK) Stock Analysis: Exploring Its 4.39% Dividend Yield and Growth Potential

For investors with a keen eye on the healthcare sector, GSK plc (NYSE: GSK) presents an intriguing opportunity. As one of the leading players in the..

Zoetis Inc. (ZTS) Investor Outlook: Exploring a 31% Upside Potential in the Animal Health Leader

Zoetis Inc. (NYSE: ZTS) stands as a titan in the realm of animal health, commanding a market capitalization of $65.61 billion. As a key player in..

Medtronic plc (MDT) Stock Analysis: Exploring a 8.15% Potential Upside in the Medical Device Sector

Medtronic plc (MDT), a titan in the healthcare sector, is a prominent player in the medical devices industry. Headquartered in Galway, Ireland, Medtronic has a robust..

Danaher Corporation (DHR) Stock Analysis: A 25% Upside Beckons Investors Amid Solid Buy Ratings

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, particularly within the diagnostics and research industry, has captured the attention of investors with a robust..

Stryker Corporation (SYK) Investor Outlook: Analyzing the 14.22% Potential Upside Amid Robust Revenue Growth

Stryker Corporation (NYSE: SYK) stands out in the healthcare sector as a formidable player in the medical devices industry. With a market capitalization of $144.43 billion,..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 20.81% Potential Upside in the Healthcare Innovator

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a titan in the healthcare industry, with a market capitalization of $173.19 billion. Specializing in medical instruments and supplies,..

Eli Lilly and Company (LLY) Stock Analysis: A Strong Healthcare Contender with 25% Upside Potential

Eli Lilly and Company (NYSE: LLY) stands out as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Evaluating an 86% Potential Upside in Biotech Innovation

Oric Pharmaceuticals, Inc. (ORIC), a burgeoning player in the biotechnology sector, is capturing significant investor interest with its innovative approach to tackling cancer resistance mechanisms. Headquartered..

Kamada Ltd. (KMDA) Stock Analysis: Investor Outlook with Nearly 100% Upside Potential

Kamada Ltd. (KMDA), an Israeli healthcare company specializing in plasma-derived protein therapeutics, is capturing the attention of investors with its noteworthy potential upside of nearly 100%...

Humacyte, Inc. (HUMA) Stock Analysis: Exploring the 309.72% Potential Upside in Biotech Innovation

Humacyte, Inc. (NASDAQ: HUMA) is making significant strides in the biotechnology sector with its pioneering approach to creating implantable, bioengineered human tissues. Headquartered in Durham, North..

PureTech Health plc (PRTC) Stock Analysis: Exploring a 145.99% Upside in the Biotechnology Space

For investors seeking opportunities within the biotechnology sector, PureTech Health plc (NASDAQ: PRTC) presents a compelling case. With a notable potential upside of 145.99%, this Boston-based..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a 44.74% Potential Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling opportunity for investors seeking exposure..

EyePoint Pharmaceuticals, Inc. (EYPT): Investor Outlook Reveals 222% Potential Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is increasingly becoming a focal point for investors in the biotechnology sector, particularly due to its promising pipeline and substantial potential..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds